Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Neuroscience ; 346: 102-112, 2017 03 27.
Artículo en Inglés | MEDLINE | ID: mdl-28093215

RESUMEN

The melanocortin 4 receptor (MC4R) is a G protein-coupled receptor (GPCR) that is expressed in several brain nuclei playing a crucial role in the regulation of energy balance controlling the homeostasis of the organism. It displays both agonist-evoked and constitutive activity, and moreover, it can couple to different G proteins. Most of the research on MC4R has been focused on agonist-induced activity, while the molecular and cellular basis of MC4R constitutive activity remains scarcely studied. We have previously shown that neuronal N-type voltage-gated calcium channels (CaV2.2) are inhibited by MC4R agonist-dependent activation, while the CaV subtypes that carry L- and P/Q-type current are not. Here, we tested the hypothesis that MC4R constitutive activity can affect CaV, with focus on the channel subtypes that can control transcriptional activity coupled to depolarization (L-type, CaV1.2/1.3) and neurotransmitter release (N- and P/Q-type, CaV2.2 and CaV2.1). We found that MC4R constitutive activity inhibits specifically CaV1.2/1.3 and CaV2.1 subtypes of CaV. We also explored the signaling pathways mediating this inhibition, and thus propose that agonist-dependent and basal MC4R activation modes signal differentially through Gs and Gi/o pathways to impact on different CaV subtypes. In addition, we found that chronic incubation with MC4R endogenous inverse agonist, agouti and agouti-related peptide (AgRP), occludes CaV inhibition in a cell line and in amygdaloid complex cultured neurons as well. Thus, we define new mechanisms of control of the main mediators of depolarization-induced calcium entry into neurons by a GPCR that displays constitutive activity.


Asunto(s)
Canales de Calcio Tipo L/fisiología , Neuronas/fisiología , Receptor de Melanocortina Tipo 4/fisiología , Proteína Relacionada con Agouti/administración & dosificación , Amígdala del Cerebelo/metabolismo , Amígdala del Cerebelo/fisiología , Animales , Femenino , Proteínas de Unión al GTP/metabolismo , Células HEK293 , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Neuronas/metabolismo , Proteínas Proto-Oncogénicas c-fos/metabolismo , Receptor de Melanocortina Tipo 4/agonistas , Transducción de Señal
2.
Horm Behav ; 67: 66-72, 2015 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-25499794

RESUMEN

Ghrelin (Grh) is an endogenous ligand of the growth hormone secretagogue receptor. In neonatal chicks, central Ghr induces anxiogenic-like behavior but strongly inhibits food intake. The intermediate medial mesopallium (IMM) of the chick forebrain has been identified to be a site of the memory formation, and the modulation of the GABAA receptors that are present here modifies the expression of behavior. Thus, the GABAergic system may constitute a central pathway for Ghr action in regulating the processes of food intake and stress-related behaviors. Therefore, we investigated if the effect of systemic administration of bicuculline (GABAA receptor antagonist) and diazepam (benzodiazepine receptor agonist) on the anxiety in an Open Field test and inhibition in food intake induced by Grh (30pmol) when injected into IMM, were mediated by GABAergic transmission. In Open Field test, bicuculline was able to block the anxiogenic-like behavior induced by Ghr, whereas diazepam did not produce it. However, the co-administration of bicuculline or diazepam plus Ghr did not show any change in food intake at 30, 60 and 120min after injection compared to Ghr alone. Our results indicate for the first time that Ghr, injected into the forebrain IMM area, induces an anxiogenic-like behavior, which was blocked by bicuculline but not diazepam, thus suggesting that Ghr plays an important role in the response pattern to acute stressor, involving the possible participation of the GABAergic system. Nevertheless, as neither drug affected the hypophagia induced by intra-IMM Ghr, this suggests that it may be mediated by different mechanisms.


Asunto(s)
Ansiedad/metabolismo , Conducta Animal/fisiología , Cerebro/metabolismo , Ingestión de Alimentos/fisiología , Ghrelina/fisiología , Receptores de GABA-A/fisiología , Animales , Animales Recién Nacidos , Ansiedad/inducido químicamente , Conducta Animal/efectos de los fármacos , Cerebro/efectos de los fármacos , Pollos , Ingestión de Alimentos/efectos de los fármacos , Femenino , Ghrelina/administración & dosificación , Ghrelina/farmacología , Masculino
3.
Neuroscience ; 197: 145-52, 2011 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-21978882

RESUMEN

A 13-amino acid peptide named neuronostatin (NST) encoded in the somatostatin pro-hormone has been recently reported. It is produced throughout the body, particularly in brain areas that have significant actions over the metabolic and autonomic regulation. The present study was performed in order to elucidate the functional role of NST on memory, anxiety-like behavior and food intake and the hippocampal participation in these effects. When the peptide was intra-hippocampally administered at 3.0 nmol/µl, it impaired memory retention in both, object recognition and step-down test. Also, this dose blocked the hippocampal long-term potentiation (LTP) generation. When NST was intra-hippocampally administered at 0.3 nmol/µl and 3.0 nmol/µl, anxiolytic effects were observed. Also, the administration in the third ventricle at the higher dose (3.0 nmol/µl) induced similar effects, and both doses reduced food intake. The main result of the present study is the relevance of the hippocampal formation in the behavioral effects induced by NST, and these effects could be associated to a reduced hippocampal synaptic plasticity.


Asunto(s)
Ansiedad/metabolismo , Ingestión de Alimentos/fisiología , Hipocampo/metabolismo , Memoria/fisiología , Fragmentos de Péptidos/metabolismo , Somatostatina/metabolismo , Animales , Ingestión de Alimentos/efectos de los fármacos , Hipocampo/efectos de los fármacos , Potenciación a Largo Plazo/efectos de los fármacos , Potenciación a Largo Plazo/fisiología , Masculino , Aprendizaje por Laberinto/efectos de los fármacos , Aprendizaje por Laberinto/fisiología , Memoria/efectos de los fármacos , Técnicas de Placa-Clamp , Ratas , Ratas Wistar
4.
Neuroscience ; 153(4): 929-34, 2008 Jun 02.
Artículo en Inglés | MEDLINE | ID: mdl-18434026

RESUMEN

It has been demonstrated, in normal and aged rats and mice, that acute i.c.v. ghrelin (Ghr) administration increases memory retention. In order to evaluate if this treatment, restores memory retention in animals exhibiting impaired memory, in the present work we selected a chronic food restriction mouse model (since undernutrition prejudices higher nervous functions). We employed adult female mice with 28 days of 50% food restriction and evaluated: a) behavioral performance using novel object recognition test for memory, and plus maze for anxiety-like behavior, b) some morphometric parameters as body and hepatic weights and c) plasma Ghr levels. The animals with 50% food restriction showed an increase in plasma Ghr levels and a decrease in morphometric parameters and in the percentage of novel object recognition time. When the peptide was i.c.v. injected in food-restricted animals (0.03, 0.3 or 3.0 nmol/microl), memory increases in relation to food-restricted mice injected with vehicle, reaching a performance similar to controls.


Asunto(s)
Conducta Exploratoria/efectos de los fármacos , Ghrelina/administración & dosificación , Trastornos de la Memoria/tratamiento farmacológico , Trastornos de la Memoria/etiología , Reconocimiento en Psicología/efectos de los fármacos , Inanición/complicaciones , Análisis de Varianza , Animales , Conducta Animal , Peso Corporal/fisiología , Modelos Animales de Enfermedad , Relación Dosis-Respuesta a Droga , Conducta Exploratoria/fisiología , Femenino , Ghrelina/sangre , Hígado/efectos de los fármacos , Hígado/fisiología , Aprendizaje por Laberinto/efectos de los fármacos , Trastornos de la Memoria/patología , Ratones , Tamaño de los Órganos/efectos de los fármacos , Tamaño de los Órganos/fisiología , Factores de Tiempo
5.
Neuropeptides ; 34(3-4): 211-5, 2000.
Artículo en Inglés | MEDLINE | ID: mdl-11021982

RESUMEN

Earlier data have indicated that alpha-MSH may play a role for sexual behavior in rats. In this study we investigated the effects of MSH peptides on sexual receptivity in ovariectomized-adrenalectomized female rats, pre-treated with benzoate of estradiol, in presence of vigorous male rats. The results show that alpha-MSH significantly increases lordosis behavior in female rats after injections into the ventromedial nucleus. Interestingly, we have for the first time shown that gamma-MSH also causes significant increase in lordosis in female rats. Furthermore, we show that HS014, an antagonist for the central MC receptors, in dose dependent manner blocks the effect of alpha-MSH on lordosis. The results indicate that the effects of MSH peptides on female sexual behaviour are mediated through a specific MC receptor, which could be the MC3 receptor.


Asunto(s)
Receptores de Corticotropina/fisiología , Conducta Sexual Animal/fisiología , Núcleo Hipotalámico Ventromedial/fisiología , alfa-MSH/farmacología , Adrenalectomía , Animales , Estradiol/farmacología , Femenino , Masculino , Microinyecciones , Neuropéptidos/farmacología , Ovariectomía , Péptidos Cíclicos/farmacología , Postura , Ratas , Ratas Wistar , Receptores de Corticotropina/antagonistas & inhibidores , Receptores de Melanocortina , Conducta Sexual Animal/efectos de los fármacos , Núcleo Hipotalámico Ventromedial/efectos de los fármacos
6.
Neuropeptides ; 34(2): 77-82, 2000 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-10985923

RESUMEN

It is well established that melanocortic peptides, such as melanocyte-stimulating hormone (MSH) and adrenocorticotropin, induce grooming behavior. The MC3 and MC4 receptors are the MC receptors which are most abundantly expressed in the brain. gamma-MSH, a peptide with preference to the MC3 receptor, however, does not induce grooming. Recent studies have shown that MC4 receptor antagonists are very effective in inhibiting alpha-MSH induced grooming. These data have indicated that grooming behavior in rodents may be mediated by the MC4 receptor. In this study we investigated if the recently developed MC1 receptor selective agonist MS05 was able to induce grooming in comparison with alpha-MSH. The results show that MS05 is effective in inducing grooming after either intracerebroventricular or ventral tegmental area administration in rats. Central administration of either MS05 or alpha-MSH besides grooming also induced stretching, yawning, rearing and locomotion. The results indicate that the earlier hypothesis that the MC4 receptor is the main mediator of grooming behavior has to be modified. Moreover, as this behaviour does not pharmacologically correlate to the profile of any of the five cloned MC receptors, we suggest that alpha-MSH induced grooming may not primarily be mediated by any of these receptors.


Asunto(s)
Aseo Animal , Hormonas Estimuladoras de los Melanocitos/farmacología , Receptores de Corticotropina/fisiología , Animales , Clonación Molecular , Locomoción/efectos de los fármacos , Masculino , Hormonas Estimuladoras de los Melanocitos/química , Microinyecciones , Péptidos/química , Péptidos/farmacología , Ratas , Receptor de Melanocortina Tipo 3 , Receptor de Melanocortina Tipo 4 , Receptores de Corticotropina/agonistas , Receptores de Corticotropina/metabolismo , Receptores de Melanocortina
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA